Cargando…
Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia
Heat shock proteins (Hsp) are increasingly employed as therapeutic targets in oncology. We have shown that Hsp32, also known as heme oxygenase-1 (HO-1), serves as survival factor and potential target in Ph(+) chronic myeloid leukemia. We here report that primary cells and cell lines derived from pat...
Autores principales: | Cerny-Reiterer, Sabine, Meyer, Renata A., Herrmann, Harald, Peter, Barbara, Gleixner, Karoline V., Stefanzl, Gabriele, Hadzijusufovic, Emir, Pickl, Winfried F., Sperr, Wolfgang R., Melo, Junia V., Maeda, Hiroshi, Jäger, Ulrich, Valent, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012724/ https://www.ncbi.nlm.nih.gov/pubmed/24681707 |
Ejemplares similares
-
Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018) -
The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells
por: Stefanzl, Gabriele, et al.
Publicado: (2017) -
Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56(bright) NK cell subpopulations in patients with acute myeloid leukemia and supports their activation
por: Cuapio, Angélica, et al.
Publicado: (2016) -
In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2020) -
NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation
por: Hadzijusufovic, E, et al.
Publicado: (2012)